Overview

Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.

Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
To assess the impact on glucose control by inhaled insulin alone or added to two oral anti-diabetic agents in patients with type 2 diabetes who are not well controlled on 2 oral anti-diabetic agents.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Collaborators:
Nektar Therapeutics
Sanofi
Treatments:
Insulin
Insulin, Globin Zinc